Salt restriction and increased insulin production in hypertensive patients

References

• McKeigue P M, Shah B, Marmot M G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382–6
   PubMed Web of Science ®Google Scholar
• Salomaa W, Strandberg T E, Vanhanen H, Naukkarinen V, Sarna S, Miettinen T A. Glucose tolerance and blood pressure: long term follow up in middle aged men. BMJ 1991; 302: 493–6
   PubMed Web of Science ®Google Scholar
• Ferranini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7
   PubMed Web of Science ®Google Scholar
• Rocchini A P, Katch V, Kveselis D, et al. Insulin and renal sodium retention in obese adolescents. Hypertension 1989; 14: 367–74
   PubMed Web of Science ®Google Scholar
• Cederholm J, Wibell L. Insulin resistance in the oral glucose tolerance test-a link with hypertension. Scand J Prim Health Care 1991; 9: 53–7
   PubMedGoogle Scholar
• Fisher M. Guide to clinical preventive services. William & Wilkins, Baltimore 1989; 305–14, Report of the US Preventive Services Task Force
   Google Scholar
• Iwaoka T, Umeda T, Ohno M, et al. The effect of low and high NaCl diets on oral glucose tolerance. Klin Wochenschr 1988; 66: 724–8
   PubMedGoogle Scholar
• Sharma A M, Ruland K, Spies K P, Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 1991; 9: 329–35
   PubMed Web of Science ®Google Scholar
• Meland E, Laerum E, Ulvik R J. Salt restriction in hypertension. The effect of dietary advice and self monitoring of chloride concentration in urine. Scand J Clin Lab Invest 1994; 00: 00–00
   Google Scholar
• Goldstein D S. Modified sample preparation for high-performance liquid chromatographic-electro-chemical assay of urinary catecholamines. J Chro-matogr 1983; 275: 174–7
   PubMedGoogle Scholar
• Joseph M H, Kadam B V, Risby D. Simple high-performance liquid chromatographic method for the concurrent determination of the amine metabolites vanillylmandelic acid, 3-methoxy-4-hydroxy-phenylacetic acid and homovanillic acid in urine using electrochemial detection. J Chromatogr 1981; 226: 361–8
   PubMed Web of Science ®Google Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Norusis M J. SPSS Inc., Chicago 1988; B190–2, SPSS/PC+ V2.0. Base manual
   Google Scholar
• Thorburne A W, Brand J C, Truswell A S. Salt and the glycemic response. BMJ 1986; 292: 1697–9
   Google Scholar
• Ferranini E, Barrett E, Bevilacqua S, Dupre J, Defronzo R A. Sodium elevates the plasma glucose response to glucose ingestion in man. J Clin Endocrinol Metab 1982; 54: 455–8
   Google Scholar
• Dodson P M, Beevers M, Hallworth R, Webberley M J, Fletcher R F, Taylor K G. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 1989; 298: 227–30
   PubMedGoogle Scholar
• de Fronzo R A. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 1981; 21: 165–71
   Web of Science ®Google Scholar
• de Fronzo R A, Ferranini E. Insulin resistance. A multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–94
   PubMed Web of Science ®Google Scholar
• Julius S, Gudbrandsson T, Jamerson K, Shahab S T, Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983–6
   PubMed Web of Science ®Google Scholar
• Omvik P, Lund-Johansen P. Is sodium restriction effective treatment of borderline and mild essential hypertension? A long-term hemodynamic study at rest and during exercise. J Hypertens 1986; 4: 535–41
   PubMed Web of Science ®Google Scholar
• Stout R W. Insulin and atheroma-an update. Lancet 1987; 333: 1077–9
   Google Scholar
• Cruickshank J K, Cooper J, Burnett M, MacDuff J, Drubra U. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991; 338: 842–7
   PubMed Web of Science ®Google Scholar
• Masugi F, Ogihara T, Hashizume K, Hasegawa T, Sakaguchi K, Kumahara Y. Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension. J Hum Hypertens 1988; 1: 293–8
   PubMed Web of Science ®Google Scholar
• Romoff M S, Keusch G, Campese V M, et al. Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metabol 1978; 48: 26–31
   Web of Science ®Google Scholar
• Warren S E, Vieweg W VR, O'Connor D T. Sympathetic nervous system activity during sodium restriction in essential hypertension. Clin Cardiol 1980; 3: 348–51
   Google Scholar
• Kjeldsen S E, Os I, Beckmann S L, et al. Decreased noradrenergic sympathetic tone during controlled long-term low sodium treatment of mild essential hypertension. J Hypertens Suppl 1986; 4(Suppl. 6)S200–2
   Google Scholar
• Rocchini A P, Key D, Bondie D. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989; 321: 580–5
   PubMed Web of Science ®Google Scholar